HomeCompareCZA vs JNJ

CZA vs JNJ: Dividend Comparison 2026

CZA yields 1.58% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CZA wins by $2.0K in total portfolio value
10 years
CZA
CZA
● Live price
1.58%
Share price
$108.90
Annual div
$1.73
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.0K
Annual income
$175.53
Full CZA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CZA vs JNJ

📍 CZA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCZAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CZA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CZA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CZA
Annual income on $10K today (after 15% tax)
$134.65/yr
After 10yr DRIP, annual income (after tax)
$149.20/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $554.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CZA + JNJ for your $10,000?

CZA: 50%JNJ: 50%
100% JNJ50/50100% CZA
Portfolio after 10yr
$21.0K
Annual income
$501.65/yr
Blended yield
2.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CZA
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CZA buys
0
JNJ buys
0
No recent congressional trades found for CZA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCZAJNJ
Forward yield1.58%3.36%
Annual dividend / share$1.73$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$22.0K$20.0K
Annual income after 10y$175.53$827.78
Total dividends collected$1.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CZA vs JNJ ($10,000, DRIP)

YearCZA PortfolioCZA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,858$158.41$10,676$355.77+$182.00CZA
2$11,779$160.76$11,407$389.39+$372.00CZA
3$12,767$162.98$12,198$426.53+$569.00CZA
4$13,826$165.09$13,056$467.62+$770.00CZA
5$14,960$167.08$13,987$513.12+$973.00CZA
6$16,177$168.97$14,998$563.56+$1.2KCZA
7$17,480$170.75$16,098$619.52+$1.4KCZA
8$18,876$172.44$17,295$681.69+$1.6KCZA
9$20,371$174.03$18,599$750.82+$1.8KCZA
10$21,973$175.53$20,022$827.78+$2.0KCZA

CZA vs JNJ: Complete Analysis 2026

CZAStock

The Invesco Zacks Mid-Cap ETF (Fund) is based on the Zacks Mid-Cap Core Index (Index). The Fund will invest at least 90% of its total assets in securities that comprise the Index. The Index selects securities from a universe of mid-capitalization securities, including master limited partnerships (MLPs) and American depositary receipts (ADRs)and business development companies (BDCs). The Fund and the Index are rebalanced quarterly.

Full CZA Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CZA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CZA vs SCHDCZA vs JEPICZA vs OCZA vs KOCZA vs MAINCZA vs ABBVCZA vs MRKCZA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.